These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12181237)

  • 21. A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinoma.
    Ducreux M; Rougier P; Pignon JP; Douillard JY; Seitz JF; Bugat R; Bosset JF; Merouche Y; Raoul JL; Ychou M; Adenis A; Berthault-Cvitkovic F; Luboinski M;
    Ann Oncol; 2002 Aug; 13(8):1185-91. PubMed ID: 12181240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identifying ideal candidates for nanoliposomal topoisomerase inhibitors in metastatic pancreatic adenocarcinoma.
    Yu K
    Clin Adv Hematol Oncol; 2018 Sep; 16 Suppl 17(9):9-10. PubMed ID: 30807562
    [No Abstract]   [Full Text] [Related]  

  • 23. A case of pancreatic cancer achieving symptomatic improvement with systemic chemotherapy.
    Kosakamoto H; Okada S; Ueno H; Okusaka T; Ikeda M; Tanaka N; Yoshimori M; Matsuno Y
    Hepatogastroenterology; 1999; 46(28):2621-4. PubMed ID: 10522052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mount Sinai clinical experience with leucovorin and 5-fluorouracil.
    Bruckner HW
    Adv Exp Med Biol; 1988; 244():157-66. PubMed ID: 3073652
    [No Abstract]   [Full Text] [Related]  

  • 25. Concomitant intraarterial cisplatin, intravenous 5-flourouracil, and split-course radiation therapy for locally advanced unresectable pancreatic adenocarcinoma: a phase II study of the Puget Sound Oncology Consortium (PSOC-703).
    Thomas CR; Weiden PL; Traverso LW; Thompson T
    Am J Clin Oncol; 1997 Apr; 20(2):161-5. PubMed ID: 9124192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complete pathologic responses to preoperative chemoradiation in two patients with adenocarcinoma of the pancreas.
    Magnin V; Viret F; Moutardier V; Lelong B; Giovannini M; Monges G; Delpero JR
    Pancreas; 2004 Jan; 28(1):103-4. PubMed ID: 14707739
    [No Abstract]   [Full Text] [Related]  

  • 27. Epirubicin, etoposide and cisplatin in advanced pancreatic carcinoma.
    Di Bartolomeo M; Zampino MG; Di Leo A; Bajetta E
    Eur J Cancer; 1993; 29A(8):1215-6. PubMed ID: 8518036
    [No Abstract]   [Full Text] [Related]  

  • 28. Open-label, multicenter, randomized phase III trial of adjuvant chemoradiation plus interferon Alfa-2b versus fluorouracil and folinic acid for patients with resected pancreatic adenocarcinoma.
    Schmidt J; Abel U; Debus J; Harig S; Hoffmann K; Herrmann T; Bartsch D; Klein J; Mansmann U; Jäger D; Capussotti L; Kunz R; Büchler MW
    J Clin Oncol; 2012 Nov; 30(33):4077-83. PubMed ID: 23008325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-dose folinic acid, 5-fluorouracil bolus and infusion in advanced pancreatic adenocarcinoma: a pilot study.
    Louvet C; Beerblock K; de Gramont A; Varette C; Demuynck B; Bennamoun M; Cady J; Delfau S; Maisani JE; Krulik M
    Eur J Cancer; 1993; 29A(8):1217. PubMed ID: 8518038
    [No Abstract]   [Full Text] [Related]  

  • 30. [Therapy of locally advanced pancreatic cancer with FOLFIRINOX].
    Strobel O; Büchler MW
    Chirurg; 2016 Aug; 87(8):699. PubMed ID: 27418266
    [No Abstract]   [Full Text] [Related]  

  • 31. Pancreatic adenocarcinoma responding to cisplatin based cytotoxic chemotherapy.
    Marshall E; Trotter JM; Metcalf C
    Aust N Z J Med; 1991 Oct; 21(5):780-1. PubMed ID: 1722092
    [No Abstract]   [Full Text] [Related]  

  • 32. Arterial infusion chemotherapy for the patient of unresectable pancreatic carcinoma with multiple liver metastases: a case report.
    Fujii M; Miyake H; Sasaki K; Takagi T; Takamura K; Tashiro S
    J Med Invest; 2003 Aug; 50(3-4):199-202. PubMed ID: 13678391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advanced pancreatic cancer successfully treated with continuous infusion of 5-fluorouracil and low-dose cisplatin.
    Kikuchi H; Ujiie S; Kanamaru R
    Intern Med; 1998 Jul; 37(7):635-7. PubMed ID: 9711896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Response to doxorubicin/methotrexate/fluorouracil in advanced adenocarcinoma of pancreas or biliary tract.
    Pyrhönen S; Valtonen M
    Lancet; 1990 Jul; 336(8707):127. PubMed ID: 1975317
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of advanced digestive non-colon cancer with a weekly 24-h infusion of high-dose 5-fluorouracil modulated by folinic acid and cisplatin: an easy-to-use and well-tolerated combination.
    Delaunoit T; Maréchal R; Hendlisz A; Eisendrath P; Legendre H; Pector JC; De Becker D; Bleiberg H
    Anticancer Drugs; 2004 Aug; 15(7):725-8. PubMed ID: 15269605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ifosfamide plus 5-fluorouracil for treatment of adenocarcinoma of the pancreas.
    Loehrer PJ; Williams SD; Nichols CR
    Cancer Treat Rep; 1987 Nov; 71(11):1115-6. PubMed ID: 3119208
    [No Abstract]   [Full Text] [Related]  

  • 37. A phase II study of continuous-infusion 5-fluorouracil with cisplatin and epirubicin in inoperable pancreatic cancer.
    Evans TR; Lofts FJ; Mansi JL; Glees JP; Dalgleish AG; Knight MJ
    Br J Cancer; 1996 May; 73(10):1260-4. PubMed ID: 8630289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cure of advanced gastric cancer by combined chemotherapy with cisplatinum, mitomycin C, and 5-fluorouracil.
    Tanemura H; Kawata R; Suzuki M; Shimokawa K; Azuma S; Furuta T; Saji S; Ohashi H; Sakata K
    J Surg Oncol; 1988 May; 38(1):26-32. PubMed ID: 3131592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase III trial on the therapy of advanced pancreatic carcinoma. Evaluations of the Mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin.
    Cullinan S; Moertel CG; Wieand HS; Schutt AJ; Krook JE; Foley JF; Norris BD; Kardinal CG; Tschetter LK; Barlow JF
    Cancer; 1990 May; 65(10):2207-12. PubMed ID: 2189551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical response to systemic combined chemotherapy with 5-fluorouracil and cisplatin (FP therapy) in patients with advanced pancreatic cancer.
    Okusaka T; Okada S; Ishii H; Nose H; Nakasuka H; Nakayama H; Nagahama H
    Jpn J Clin Oncol; 1996 Aug; 26(4):215-20. PubMed ID: 8765178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.